Advertisement
News
Advertisement

Cancer: Accuray lands 510(k) clearance for next-gen CyberKnife

Fri, 11/02/2012 - 2:55pm
Mass Device

The FDA grants 510(k) clearance to Accuray's CyberKnife M6 radiosurgery device for treating cancerous tumors.

Accuray

Accuray (NSDQ:ARAY) won 510(k) clearance from the FDA for the latest iteration of its CyberKnife radiosurgery device.

Chief commercial officer Kelly Londy told MassDevice.com that the Sunnyvale, Calif.-based medical device company is launching the product immediately.

Unlike other radiosurgery devices, which deliver a targeted beam of radiation to destroy cancerous tumor cells, the CyberKnife M6 tracks and adjusts for any physical movement of the tumor.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading